TrialChinese medical journal2019

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study.

Ying Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.